agreed. for me that is a real risk but I am hopeful that assuming we get fda approval, a deal and hence funding then the noise around management will subside and then par can do what they have done well so far which is execute on the trials. that's your second leg.
I would like to think once we get through this phase and let's say have 350/400m shares and let's just say $2, with a market cap of 750/800m and are borderline asx200 we can attract a good ceo and PR takes the chair or visa versa and then that piece could be solved too. that's your 3rd leg.
wishful thinking maybe but that's my upside thesis.
Sharewise Presentation 22/7/24, page-57
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.020(8.51%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 25.5¢ | 23.5¢ | $161.2K | 660.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 77422 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 15109 | 1 |
View Market Depth
| Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |